← Back to Search

Psychosocial Intervention for Dementia Caregivers

N/A
Recruiting
Led By Bei Wu, PhD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meet specific cardiometabolic and depressive symptom criteria: Cardiometabolic syndrome: It will not be required to submit objective measurement of cardiometabolic disorder, self-reported medical conditions will be accepted for enrollment. Diabetes: self-reported OR A1C >= 5.7% OR High Cholesterol: self-reported OR low-density lipoprotein (LDL) > 130 mg/dL or total cholesterol > 200 mg/dL (American Heart Association 2018) OR Hypertension: self-reported OR systolic blood pressure (SBP) >= 130 mmHg or diastolic blood pressure (DBP) >= 80mmHg (2017 ACC/AHA hypertension guideline) OR Body Mass Index > 23 kg/m2 by self-reported or measured height and weight (WHO expert consultation regarding Asian cut-off).
Capable of completing informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial tests a culturally tailored intervention to reduce health risks for caregivers of people with Alzheimer's & other dementias (ADRD). It seeks to improve psychosocial factors, self-rated health & chronic disease mgmt for Chinese & Korean American caregivers.

Who is the study for?
This trial is for older Chinese and Korean American adults (50+) in New York or Bergen County, NJ who are primary caregivers for relatives with dementia. They must have internet access, read English/Chinese/Korean, and meet certain health criteria like diabetes or high cholesterol but not be dealing with substance abuse or recent psychiatric hospitalizations.Check my eligibility
What is being tested?
The study tests a culturally tailored support program (NYUCI-ES) that includes counseling and online peer groups via WeChat/Kakaotalk to improve mental health and manage chronic diseases in caregivers. The goal is to see if this intervention reduces stress, depression, improves social support, self-rated health, and lowers risk factors for heart disease within 6 months.See study design
What are the potential side effects?
Since the intervention involves psychosocial support rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort discussing personal issues during counseling sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have or might have diabetes, high cholesterol, high blood pressure, or am overweight.
Select...
I can understand and agree to the study's details.
Select...
I am 50 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
BMI
Caregiving related stress
Chronic disease self management behaviors
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
Treatment group will receive 6 counseling sessions, participate in local support group and on-line chat group, and receive "ad hoc' counseling.
Group II: Control GroupActive Control1 Intervention
Control group will participate in on-line chat group, and call the counselor for resource information and support as needed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment Group
2012
N/A
~1160

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
225 Previous Clinical Trials
312,575 Total Patients Enrolled
6 Trials studying Obesity
3,018 Patients Enrolled for Obesity
NYU Langone HealthOTHER
1,363 Previous Clinical Trials
816,186 Total Patients Enrolled
26 Trials studying Obesity
10,995 Patients Enrolled for Obesity
Rutgers UniversityOTHER
113 Previous Clinical Trials
2,803,799 Total Patients Enrolled
4 Trials studying Obesity
577 Patients Enrolled for Obesity

Media Library

Treatment Group Clinical Trial Eligibility Overview. Trial Name: NCT05461495 — N/A
Obesity Research Study Groups: Treatment Group, Control Group
Obesity Clinical Trial 2023: Treatment Group Highlights & Side Effects. Trial Name: NCT05461495 — N/A
Treatment Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05461495 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals can sign up for this medical research project?

"Affirmative. Clinicaltrials.gov reveals that the search for trial participants is currently underway with an initial post date of February 1st, 2023 and a recent update on February 23rd, 2023. The study requires 300 individuals to be recruited from one location."

Answered by AI

Are participants still being enrolled in this clinical investigation?

"Affirmative. According to the information on clinicaltrials.gov, this medical research is currently in need of volunteers for participation. This project was initially posted on February 1st 2023 and has been revised as recently as February 23rd 2023. The experiment aims to enlist 300 participants from one single facility."

Answered by AI
~200 spots leftby Jun 2026